The DOI matches its Crossref record; 377 of the 377 references it cites were found in a registry or an index.
Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–377 of 377
Ciechomska, I. A., Gabrusiewicz, K. R., Szczepankiewicz, A. A., & Kaminska, B. (2012) · Oncogene · doi:10.1038/onc.2012.174 · Cited by 149
Kolenda, J., Jensen, S. S., Aaberg-Jessen, C., Christensen, K., Andersen, C., Brünner, N., & Kristensen, B. W. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0357-8 · Cited by 144
Physiological and Pharmacological Control of BAK, BAX, and Beyond
Luna-Vargas, M. P. A., & Chipuk, J. E. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.07.002 · Cited by 142
HMGB1: Roles in base excision repair and related function
Liu, Y., Prasad, R., & Wilson, S. H. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.11.008 · Cited by 140
Cancer stem cell contribution to glioblastoma invasiveness
Ortensi, B., Setti, M., Osti, D., & Pelicci, G. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt166 · Cited by 139
Williams, M. M., & Cook, R. S. (2015) · Oncotarget · doi:10.18632/oncotarget.2792 · Cited by 137
The prognostic role of Beclin 1 protein expression in high-grade gliomas
Pirtoli, L., Cevenini, G., Tini, P., Vannini, M., Oliveri, G., Marsili, S., Mourmouras, V., Rubino, G. F., & Miracco, C. (2009) · Autophagy · doi:10.4161/auto.5.7.9227 · Cited by 137
Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design
Łoś, M., Burek, C. J., Stroh, C., Benedyk, K., Hug, H., & Mackiewicz, A. A. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02563-1 · Cited by 136
Lin, C., Lee, C.-C., Shih, Y., Lin, C., Wang, S.-H., Chen, T.-H., & Shih, C.-M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038706 · Cited by 135
Ma, K., Ivanov, V. N., Dong, J., & Ronai, Z. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206598 · Cited by 135
Filippi‐Chiela, E. C., Thomé, M. P. M., Silva, M. M. B. E., Pelegrini, A. L., Ledur, P. F., Garicochea, B., Zamin, L. L., & Lenz, G. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-147 · Cited by 135
Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets
Codrici, E., Enciu, A., Popescu, I. D., Mihai, S., & Tănase, C. (2016) · Stem Cells International · doi:10.1155/2016/5728438 · Cited by 135
Postoperative Irradiation of Glioblastomas: Results in a Randomized Series
Andersen, A. P. (1978) · Acta Radiologica Oncology Radiation Physics Biology · doi:10.3109/02841867809128178 · Cited by 134
Ghavami, S., Yeganeh, B., Stelmack, G. L., Kashani, H. H., Sharma, P. K., Cunnington, R. H., Rattan, S. G., Bathe, K. L., Klonisch, T. C., Dixon, I., et al. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.61 · Cited by 133
Self-citationGupta, S. K., Kizilbash, S. H., Carlson, B. L., Mladek, A. C., Boakye‐Agyeman, F., Bakken, K. K., Pokorny, J. L., Schroeder, M. A., Decker, P. A., Cen, L., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv369 · Cited by 133
McFaline‐Figueroa, J. L., Braun, C. J., Stanciu, M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3616 · Cited by 131
DNA Repair Capacity in Multiple Pathways Predicts Chemoresistance in Glioblastoma Multiforme
Nagel, Z. D., Kitange, G. J., Gupta, S. K., Joughin, B. A., Chaim, I. A., Mazzucato, P., Lauffenburger, D. A., Sarkaria, J. N., & Samson, L. D. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1151 · Cited by 131
Chloroquine Eliminates Cancer Stem Cells Through Deregulation of Jak2 and DNMT1
Choi, D. S., Blanco, E., Kim, Y.-S., Rodriguez, A. A., Zhao, H., Huang, T. H. ‐., Chen, C., Jin, G., Landis, M. D., Burey, L. A., et al. (2014) · Stem Cells · doi:10.1002/stem.1746 · Cited by 129
Tang, J.-B., Svilar, D., Trivedi, R. N., Wang, X., Goellner, E. M., Moore, B., Hamilton, R. L., Banze, L. A., Brown, A. R., & Sobol, R. W. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor011 · Cited by 127
Yoshimoto, K., Mizoguchi, M., Hata, N., Murata, H., Hatae, R., Amano, T., Nakamizo, A., & Sasaki, T. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00186 · Cited by 126
Aoki, H., Kondo, Y., Aldape, K., Yamamoto, A., Iwado, E., Yokoyama, T., Hollingsworth, E., Kobayashi, R., Hess, K. R., Shinojima, N., et al. (2008) · Autophagy · doi:10.4161/auto.5668 · Cited by 126
Autophagy: a pathway that contributes to connexin degradation
Lichtenstein, A., Minogue, P. J., Beyer, E. C., & Berthoud, V. M. (2011) · Journal of Cell Science · doi:10.1242/jcs.073072 · Cited by 125
Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial
Xu, R., Shimizu, F., Hovinga, K. E., Beal, K. P., Karimi, S., Droms, L. A., Peck, K. K., Gutin, P. H., Iorgulescu, J. B., Kaley, T. J., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0048 · Cited by 125
Lee, S. W., Kim, H.-K., Lee, N. H., Yi, H.-Y., Kim, H.-S., Hong, S. H., Hong, Y.-K., & Joe, Y. A. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.012 · Cited by 123
The ATF6 pathway of the ER stress response contributes to enhanced viability in glioblastoma
Dadey, D. Y. A., Kapoor, V., Khudanyan, A., Urano, F., Kim, A. H., Thotala, D. K., & Hallahan, D. E. (2015) · Oncotarget · doi:10.18632/oncotarget.6712 · Cited by 122
Control of glioblastoma tumorigenesis by feed-forward cytokine signaling
Jahani‐Asl, A., Yin, H., Soleimani, V. D., Haque, T., Luchman, H. A., Chang, N. C., Sincennes, M., Puram, S. V., Scott, A. M., Lorimer, I. A. J., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4295 · Cited by 122
Fulton, D. S., Urtasun, R. C., & Forsyth, P. A. (1996) · Journal of Neuro-Oncology · doi:10.1007/bf00177478 · Cited by 121
Dirks, P. B. (2006) · Nature · doi:10.1038/444687a · Cited by 121
Phase II study of PX-866 in recurrent glioblastoma
Pitz, M. W., Eisenhauer, E. A., MacNeil, M. V., Thiessen, B. A., Easaw, J. C., Macdonald, D. R., Eisenstat, D. D., Kakumanu, A. S., Salim, M., Chalchal, H. I., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nou365 · Cited by 121
Self-citationAuf, G., Jabouille, A., Delugin, M., Guérit, S., Pineau, R., North, S., Platonova, N., Maître, M., Favereaux, A., Vajkoczy, P., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-597 · Cited by 120
Florian, B.-A., Lamure, M. P., Ducray, F., Aulagner, G., Honnorat, J., & Armoiry, X. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now102 · Cited by 120
Stechishin, O. D. M., Luchman, H. A., Ruan, Y., Blough, M. D., Nguyen, S. A., Kelly, J. J., Cairncross, J. G., & Weiss, S. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos302 · Cited by 116
Suppression of autophagy impedes glioblastoma development and induces senescence
Gammoh, N., Dudley-Fraser, J., Puente, C., Syred, H. M., Kang, H. H., Ozawa, T., Lam, D., Acosta, J. C., Finch, A. J., Holland, E. C., et al. (2016) · Autophagy · doi:10.1080/15548627.2016.1190053 · Cited by 116
Filippi‐Chiela, E. C., Silva, M. M. B. E., Thomé, M. P. M., & Lenz, G. (2015) · Autophagy · doi:10.1080/15548627.2015.1009795 · Cited by 114
Tan, E., Thuault, S., Caja, L., Carletti, T., Heldin, C., & Moustakas, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.291385 · Cited by 114
Liao, H., Bai, Y., Qiu, S., Zheng, L., Huang, L., Liu, T., Wang, X., Liu, Y., Xu, N., Yan, X., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3563 · Cited by 113
Canadian Recommendations for the Treatment of Recurrent or Progressive Glioblastoma Multiforme
Easaw, J. C., Mason, W. P., Perry, J., Laperrière, N., Eisenstat, D. D., Maestro, R. F. D., Bélanger, K., Fulton, D. S., & Macdonald, D. R. (2011) · Current Oncology · doi:10.3747/co.v18i3.755 · Cited by 111
Ellis, H. P., Greenslade, M., Powell, B., Spiteri, I., Sottoriva, A., & Kurian, K. M. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00251 · Cited by 111
Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells
Munoz, J. L., Walker, N. D., Scotto, K. W., & Rameshwar, P. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.013 · Cited by 110
Villalva, C., Martin‐Lannerée, S., Cortes, U., Dkhissi, F., Wager, M., Corf, A. L., Tourani, J. M., Dusanter‐Fourt, I., Turhan, A. G., & Karayan, L. (2010) · International Journal of Cancer · doi:10.1002/ijc.25416 · Cited by 110
Endothelial cells induce cancer stem cell features in differentiated glioblastoma cells via bFGF
Fessler, E., Borovski, T., & Medema, J. P. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0420-3 · Cited by 109
Woodhouse, B. C., Dianova, I. I., Parsons, J. L., & Dianov, G. L. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.03.017 · Cited by 108
Lu, Y., Zhou, J., Xu, C., Lin, H., Xiao, J., Wang, Z., & Yang, B. (2008) · Cellular Physiology and Biochemistry · doi:10.1159/000129389 · Cited by 107
Yu, Z., Zhao, G., Xie, G., Zhao, L., Chen, Y., Yu, H., Zhang, Z., Li, C., & Li, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.5405 · Cited by 106
Roos, W. P., Nikolova, T., Quirós, S., Naumann, S. C., Kiedron, O., Zdzienicka, M. Z., & Kaina, B. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.09.003 · Cited by 106
Kerr, E. M., Holohan, C., McLaughlin, K. M., Majkut, J., Dolan, S., Redmond, K. M., Riley, J. S., McLaughlin, K. M., Stasik, I., Crudden, M. T. C. M., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.8 · Cited by 106
Epigenetic Regulation of the miR142-3p/Interleukin-6 Circuit in Glioblastoma
Chiou, G., Chien, C., Wang, M., Chen, M.-T., Yang, Y., Yu, Y., Chien, Y., Chang, Y., Shen, C., Chio, C., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.11.009 · Cited by 106
Das, A., Banik, N. L., Patel, S. J., & Ray, S. K. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-36 · Cited by 105
Motomura, K., Natsume, A., Kishida, Y., Higashi, H., Kondo, Y., Nakasu, Y., Abé, T., Namba, H., Wakai, K., & Wakabayashi, T. (2010) · Cancer · doi:10.1002/cncr.25637 · Cited by 104
Chen, W.-L., Wang, D., Du, X., He, Y., Chen, S., Shao, Q., Ma, C., Huang, B., Chen, A., Zhao, P., et al. (2015) · Medical Oncology · doi:10.1007/s12032-015-0487-0 · Cited by 104
Yacoub, A., Hamed, H. A., Allegood, J. C., Mitchell, C., Spiegel, S., Lesniak, M. S., Öğretmen, B., Dash, R., Sarkar, D., Broaddus, W. C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4043 · Cited by 104
Huang, T., Alvarez, A. A., Pangeni, R. P., Horbinski, C., Lu, S., Kim, S.-H., James, C. D., Raizer, J. J., Kessler, J. A., Brenann, C., et al. (2016) · Nature Communications · doi:10.1038/ncomms12885 · Cited by 102
Autophagy in Brain Tumors: A New Target for Therapeutic Intervention
Kaza, N., Kohli, L., & Roth, K. A. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00544.x · Cited by 101
Parsons, J. L., Dianova, I. I., Allinson, S. L., & Dianov, G. L. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04628.x · Cited by 99
Summer, H., Ou, L., Bao, Q., Zhan, L., Peter, S., Sathiyanathan, P., Henderson, D., Klonisch, T. C., Goodman, S. D., & Dröge, P. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp375 · Cited by 99
Self-citationMukherji, S. K. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1987 · Cited by 99
Tentori, L., Ricci‐Vitiani, L., Muzi, A., Ciccarone, F., Pelacchi, F., Calabrese, R., Runci, D., Pallini, R., Caiafa, P., & Graziani, G. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-151 · Cited by 98
Hori, Y. S., Hosoda, R., Akiyama, Y., Sebori, R., Wanibuchi, M., Mikami, T., Sugino, T., Suzuki, K., Maruyama, M., Tsukamoto, M., et al. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1686-9 · Cited by 96
Gliomas With 1p/19q Codeletion:a.k.a. Oligodendroglioma
Cairncross, G. J., & Jenkins, R. B. (2008) · The Cancer Journal · doi:10.1097/ppo.0b013e31818d8178 · Cited by 96
Barazzuol, L., Jena, R., Burnet, N. G., Meira, L. B., Jeynes, J. C. G., Kirkby, K. J., & Kirkby, N. F. (2013) · Radiation Oncology · doi:10.1186/1748-717x-8-65 · Cited by 96
BIRC3 is a novel driver of therapeutic resistance in Glioblastoma
Wang, D., Berglund, A., Kenchappa, R. S., Forsyth, P. A., Mulé, J. J., & Etame, A. B. (2016) · Scientific Reports · doi:10.1038/srep21710 · Cited by 95
Tec tyrosine kinase links the cytokine receptors to PI-3 kinase probably through JAK
Takahashi-Tezuka, M., Hibi, M., Fujitani, Y., Fukada, T., Yamaguchi, T., & Hirano, T. (1997) · Oncogene · doi:10.1038/sj.onc.1201071 · Cited by 91
STAT3 tyrosine phosphorylation influences survival in glioblastoma
Birner, P., Tumangelova-Yuzeir, K. D., Natchev, S., & Guentchev, M. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0195-8 · Cited by 91
Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas
Zhang, K.-L., Han, L., Chen, L., Shi, Z., Yang, M., Ren, Y., Chen, L., Zhang, J., Pu, P., & Kang, C. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.043 · Cited by 90
STAT Signaling in Glioma Cells
Swiatek-Machado, K., & Kaminska, B. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-30651-9_10 · Cited by 90
Temozolomide induces autophagy via ATM-AMPK-ULK1 pathways in glioma
Zou, Y., Wang, Q., Li, B., Xie, B., & Wang, W. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2151 · Cited by 88
Mismatch repair proteins as sensors of alkylation DNA damage
Wang, J. Y. J., & Edelmann, W. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.05.013 · Cited by 87
Hou, X., Liu, Y., Liu, H., Chen, X., Liu, M., Che, H., Guo, F., Wang, C., Zhang, D., Wu, J., et al. (2015) · Scientific Reports · doi:10.1038/srep09065 · Cited by 85
Sciuscio, D., Diserens, A., Dommelen, K. V., Martinet, D., Jones, G., Janzer, R.-C., Pollo, C., Hamou, M., Kaina, B., Stupp, R., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1931 · Cited by 84
Yahyanejad, S., King, H., Iglesias, V. S., Granton, P. V., Barbeau, L. M. O., van Hoof, S. J., Groot, A. J., Habets, R., Prickaerts, J., Chalmers, A. J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9275 · Cited by 84
Gill, S. J., Travers, J., Pshenichnaya, I., Kogera, F., Barthorpe, S., Mironenko, T., Richardson, L., Benes, C. H., Stratton, M. R., McDermott, U., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140988 · Cited by 83
Epple, L. M., Dodd, R. D., Merz, A. L., Dechkovskaia, A. M., Herring, M., Winston, B. A., Lencioni, A., Russell, R. L., Madsen, H. J., Nega, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073267 · Cited by 82
Shinsato, Y., Furukawa, T., Yunoue, S., Yonezawa, H., Minami, K., Nishizawa, Y., Ikeda, R., Kawahara, K., Yamamoto, M., Hirano, H., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1302 · Cited by 81
Sharfe, N., Dadi, H., & Roifman, C. M. (1995) · Blood · doi:10.1182/blood.v86.6.2077.bloodjournal8662077 · Cited by 80
Palumbo, S., Pirtoli, L., Tini, P., Cevenini, G., Calderaro, F., Toscano, M., Miracco, C., & Comincini, S. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24102 · Cited by 79
Noack, J., Choi, J., Richter, K., Kopp‐Schneider, A., & Régnier‐Vigouroux, A. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.384 · Cited by 79
Mao, X., Hütt-Cabezas, M., Orr, B. A., Weingart, M., Taylor, I. C., Rajan, A., Odia, Y., Kahlert, U. D., Maciaczyk, J., Nikkhah, G., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1131 · Cited by 78
Silvani, A., Eoli, M., Salmaggi, A., Lamperti, E., Maccagnano, E., Broggi, G., & Boiardi, A. (2004) · Journal of Neuro-Oncology · doi:10.1023/b:neon.0000013479.64348.69 · Cited by 78
Autophagy inhibition induces enhanced proapoptotic effects of ZD6474 in glioblastoma
Shen, J., Zheng, H., Ruan, J., Fang, W., Li, A., Tian, G., Niu, X., Luo, S., & Zhao, P. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.306 · Cited by 77
Grogan, P. T., Sarkaria, J. N., Timmermann, B. N., & Cohen, M. S. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0084-7 · Cited by 77
Pyko, I. V., Nakada, M., Sabit, H., Teng, L., Furuyama, N., Hayashi, Y., Kawakami, K., Minamoto, T., Fedulau, A., & Hamada, J. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt182 · Cited by 76
STAT Signaling in Glioma Cells
Swiatek-Machado, K., & Kaminska, B. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-4719-7_10 · Cited by 76
Iranpour, M., Moghadam, A. R., Yazdi, M., Ande, S. R., Alizadeh, J., Wiecheć, E., Lindsay, L. R., DREBOT, M. A., Coombs, K. M., & Ghavami, S. (2016) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2015.19 · Cited by 76
Self-citationAugmented HR Repair Mediates Acquired Temozolomide Resistance in Glioblastoma
del Alcazar, C. R. G., Todorova, P. K., Habib, A. A., Mukherjee, B., & Burma, S. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0125 · Cited by 76
Gli1 is a potential target for alleviating multidrug resistance of gliomas
Cui, D., Xu, Q., Wang, K., & Che, X. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.09.006 · Cited by 75
Ghavami, S., Sharma, P. K., Yeganeh, B., Ojo, O. O., Jha, A., Mutawe, M. M., Kashani, H. H., Łoś, M., Klonisch, T. C., Unruh, H. W., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.03.006 · Cited by 75
Self-citationHepatitis B and C virus-induced hepatitis: Apoptosis, autophagy, and unfolded protein response
Yeganeh, B., Moghadam, A. R., Alizadeh, J., Wiecheć, E., Alavian, S. M., Hashemi, M. M., Geramizadeh, B., Samali, A., Lankarani, K. B., Post, M., et al. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i47.13225 · Cited by 74
Self-citationCiceroni, C., Bonelli, M., Mastrantoni, E., Niccolini, C., Laurenza, M., Larocca, L. M., Pallini, R., Traficante, A., Spinsanti, P., Ricci‐Vitiani, L., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.150 · Cited by 73
Kitange, G. J., Mladek, A. C., Schroeder, M. A., Pokorny, J. C., Carlson, B. L., Zhang, Y., Nair, A., Lee, J., Yan, H., Decker, P. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.045 · Cited by 73
Riganti, C., Salaroglio, I. C., Caldera, V., Campia, I., Kopecka, J., Mellai, M., Annovazzi, L., Bosìa, A., Ghigo, D., & Schiffer, D. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not104 · Cited by 72
TTFields: where does all the skepticism come from?
Wick, W. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now012 · Cited by 72
The Leu22Pro tumor-associated variant of DNA polymerase beta is dRP lyase deficient
Dalal, S., Chikova, A. K., Jäger, J., & Sweasy, J. B. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm1053 · Cited by 70
VAMP8 facilitates cellular proliferation and temozolomide resistance in human glioma cells
Chen, Y., Meng, D., Wang, H., Sun, R., Wang, D., Wang, S., Fan, J., Zhao, Y., Wang, J., Yang, S. T., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou219 · Cited by 70
Akt and β-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line
Yi, G., Liu, Y., Xiang, W., Wang, H., Chen, Z., Xie, S., & Qi, S. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.05.054 · Cited by 69
Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy
ZHANG, Z.-S., Wang, J., SHEN, Y.-B., GUO, C.-C., Sai, K., Chen, F., MEI, X., HAN, F., & Chen, Z.-P. (2015) · Oncology Letters · doi:10.3892/ol.2015.3183 · Cited by 67
Rapkins, R. W., Wang, F., Nguyen, H. N., Cloughesy, T. F., Lai, A., Ha, W., Nowak, A. K., Hitchins, M. P., & McDonald, K. L. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov064 · Cited by 67
Effect of temozolomide on the U-118 glioma cell line
do Carmo, A., Carvalheiro, H., Crespo, I., Nunes‐Correia, I., & Lopes, M. C. (2011) · Oncology Letters · doi:10.3892/ol.2011.406 · Cited by 67
Stressed to Death: Targeting Endoplasmic Reticulum Stress Response Induced Apoptosis in Gliomas
Johnson, G. G., White, M. C., & GRIMALDI, M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795049660 · Cited by 66
Glioblastoma care in the elderly
Jordan, J. T., Gerstner, E. R., Batchelor, T. T., Cahill, D. P., & Plotkin, S. R. (2015) · Cancer · doi:10.1002/cncr.29742 · Cited by 65
Cho, H., Wang, W., Jhaveri, N., Lee, D. J., Sharma, N., Dubeau, L., Schönthal, A. H., Hofman, F. M., & Chen, T. C. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0964 · Cited by 64
A paired comparison between glioblastoma “stem cells” and differentiated cells
Schneider, M. B., Ströbele, S., Nonnenmacher, L., Siegelin, M. D., Tepper, M., Stroh, S., Hasslacher, S., Enzenmüller, S., Strauß, G., Baumann, B., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29908 · Cited by 63
Role of BNIP3 in TNF-induced cell death — TNF upregulates BNIP3 expression
Ghavami, S., Eshraghi, M., Kadkhoda, K., Mutawe, M. M., Maddika, S., Bay, G. H., Wesselborg, S., Halayko, A. J., Klonisch, T. C., & Łoś, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.01.002 · Cited by 63
Self-citationNguyen, S. A., Stechishin, O. D. M., Luchman, H. A., Lun, X. Q., Senger, D. L., Robbins, S. M., Cairncross, J. G., & Weiss, S. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1856 · Cited by 63
Nitrosoureas in the Management of Malignant Gliomas
Brandes, A. A., Bartolotti, M., Tosoni, A., & Franceschi, E. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0611-8 · Cited by 63
The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma
Kaur, H., Ali, S. Z., Huey, L., Hütt-Cabezas, M., Taylor, I. C., Mao, X., Weingart, M., Chu, Q., Rodríguez, F. J., Eberhart, C. G., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.04.020 · Cited by 63
Wee, B., Pietras, A., Ozawa, T., Bazzoli, E., Podlaha, O., Antczak, C., Westermark, B., Nelander, S., Uhrbom, L., Forsberg‐Nilsson, K., et al. (2016) · Scientific Reports · doi:10.1038/srep25956 · Cited by 62
Zhou, J., Liang, Y., Ouyang, Q., Xu, L., Cui, H., & Xu, M. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.08.027 · Cited by 61
Bak and Mcl-1 are essential for Temozolomide induced cell death in human glioma
Gratas, C., Séry, Q., Rabé, M., Oliver, L., & Vallette, F. M. (2014) · Oncotarget · doi:10.18632/oncotarget.1642 · Cited by 60
Chu, Q., Orr, B. A., Semenkow, S., Bar, E. E., & Eberhart, C. G. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2119 · Cited by 59
Ghosh, M. K., Sharma, P., Harbor, P. C., Rahaman, S. O., & Haque, S. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208894 · Cited by 58
Gli1 inhibition induces cell-cycle arrest and enhanced apoptosis in brain glioma cell lines
Wang, K., Pan, L., Che, X., Cui, D., & Li, C. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0082-3 · Cited by 57
EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma
Hiddingh, L., Tannous, B. A., Teng, J., Tops, B. B. J., Jeuken, J. W. M., Hulleman, E., Boots‐Sprenger, S., Vandertop, W. P., Noske, D. P., Kaspers, G. J. L., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1620 · Cited by 57
Scholtyssek, F., Zwiener, I., Schlamann, A., Seidel, C., Meixensberger, J., Bauer, M., Hoffmann, K., Combs, S. E., von Bueren, A. O., Kortmann, R., et al. (2013) · Radiation Oncology · doi:10.1186/1748-717x-8-161 · Cited by 57
Okada, M., Satō, A., Shibuya, K., WATANABE, E., Seino, S., Suzuki, S., Seino, M., Narita, Y., Shibui, S., Kayama, T., et al. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2209 · Cited by 57
Rath, B. H., Wahba, A., Camphausen, K. A., & Tofilon, P. J. (2015) · Cancer Medicine · doi:10.1002/cam4.510 · Cited by 56
Luchman, H. A., Stechishin, O. D. M., Nguyen, S. A., Lun, X. Q., Cairncross, J. G., & Weiss, S. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3389 · Cited by 56
MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma
Tian, T., Mingyi, M., Qiu, X., & Qiu, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.12861 · Cited by 56
McDonald, K. L., Rapkins, R. W., Olivier, J., Zhao, L., Nozue, K., Lu, D., Tiwari, S., Kuroiwa‐Trzmielina, J., Brewer, J. M., Wheeler, H., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.08.012 · Cited by 55
Yu, Z., Zhao, G., LI, P., Li, Y., Zhou, G., Chen, Y., & Xie, G. (2016) · Oncology Letters · doi:10.3892/ol.2016.4315 · Cited by 54
1p/19q testing has no significance in the workup of glioblastomas
Clark, K., Villano, J. L., Nikiforova, M. N., Hamilton, R. L., & Horbinski, C. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12031 · Cited by 53
DNA alkylation damage and autophagy induction
Bordin, D. L., Lima, M. D. S., Lenz, G., Saffi, J., Meira, L. B., Mésange, P., Soares, D. G., Larsen, A. K., Escargueil, A. E., & Henriques, J. A. P. (2013) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2013.07.001 · Cited by 53
Cartron, P., Loussouarn, D., Campone, M., Martin, S. A., & Vallette, F. M. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.150 · Cited by 53
Hamed, H. A., Yacoub, A., Park, M. A., Eulitt, P. J., Sarkar, D., Dimitrie, I. P., Chen, C., Grant, S., Curiel, D. T., Fisher, P. B., et al. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.7.11116 · Cited by 51
Hertler, C., Roth, P., Silginer, M., Florea, A., Lamszus, K., Frei, K., Deenen, R., Reifenberger, G., & Weller, M. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0772 · Cited by 51
Tumorigenic Potential of miR-18A* in Glioma Initiating Cells Requires NOTCH-1 Signaling
Turchi, L., Debruyne, D. N., Almairac, F., Virolle, V., Fareh, M., Neirijnck, Y., Burel‐Vandenbos, F., Paquis, P., Junier, M., Obberghen‐Schilling, E. V., et al. (2013) · Stem Cells · doi:10.1002/stem.1373 · Cited by 50
Stojcheva, N., Schechtmann, G., Sass, S., Roth, P., Florea, A.-M., Stefanski, A., Stühler, K., Wolter, M., Müller, N. S., Theis, F. J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7346 · Cited by 50
Wood, M. D., Reis, G. F., Reuß, D., & Phillips, J. J. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw068 · Cited by 50
Zhang, R., Wang, R., Chen, Q., & Chang, H. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3588 · Cited by 49
The roles of BECN1 and autophagy in cancer are context dependent
Gong, C., Song, E., Codogno, P., & Mehrpour, M. (2012) · Autophagy · doi:10.4161/auto.21996 · Cited by 49
Self-citationKang, C. (2011) · Oncology Reports · doi:10.3892/or.2011.1396 · Cited by 49
Tso, J. L., Yang, S., Menjivar, J. C., Yamada, K., Zhang, Y., Hong, I., Bui, Y., Stream, A., McBride, W. H., Liau, L. M., et al. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0459-1 · Cited by 49
Stark, A. M., Doukas, A., Hugo, H., & Mehdorn, H. M. (2010) · Neurological Research · doi:10.1179/016164110x12645013515052 · Cited by 47
2-Hydroxyoleic Acid Induces ER Stress and Autophagy in Various Human Glioma Cell Lines
Marcilla-Etxenike, A., Martín, M. L., Noguera-Salvà, M. A., García‐Verdugo, J. M., Soriano‐Navarro, M., Dey, I., Escribá, P. V., & Busquets, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048235 · Cited by 45
Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment
Tang, J., Ma, Z., Huang, G., Xu, Q., Xiang, Y., Li, N., Šidlauskas, K., Zhang, E. E., & Lv, S. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.04.011 · Cited by 45
Migrating glioma cells express stem cell markers and give rise to new tumors upon xenografting
Munthe, S., Sørensen, M. D., Thomassen, M., Burton, M., Kruse, T. A., Lathia, J. D., Poulsen, F. R., & Kristensen, B. W. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2221-y · Cited by 45
Majuelos‐Melguizo, J., Rodríguez, M. I., López-Jiménez, L., Rodríguez-Vargas, J. M., Martí, J. M., Serrano, S., Gavard, J., de Almodóvar, J. M. R., & Oliver, F. J. (2014) · Oncotarget · doi:10.18632/oncotarget.2993 · Cited by 44
Cancer heterogeneity: origins and implications for genetic association studies
Urbach, D., Lupien, M., Karagas, M. R., & Moore, J. H. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.07.001 · Cited by 44
Xiao, S., Yang, Z. H., Qiu, X., Lv, R., Liu, J., Wu, M., Liao, Y., & Liu, Q. (2016) · Oncotarget · doi:10.18632/oncotarget.10357 · Cited by 44
Jones, R. G., Saibil, S. D., Pun, J. M., Elford, A. R., Bonnard, M., Pellegrini, M., Arya, S., Parsons, M. E., Krawczyk, C. M., Gerondakis, S., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3790 · Cited by 43
Peymani, P., Yeganeh, B., Sabour, S., Geramizadeh, B., Fattahi, M. R., Keyvani, H., Azarpira, N., Coombs, K. M., Ghavami, S., & Lankarani, K. B. (2016) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0507 · Cited by 43
Self-citationWang, P., Wan, W., Xiong, S., Wang, J., Zou, D., Lan, C., Yu, S., Liao, B., Feng, H., & Wu, N. (2017) · Scientific Reports · doi:10.1038/s41598-017-06086-2 · Cited by 43
Fernandez-Fuente, G., Mollinedo, P., Grande, L., Vázquez-Barquero, A., & Fernández-Luna, J. L. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0854 · Cited by 42
Regulation of OSU-03012 Toxicity by ER Stress Proteins and ER Stress–Inducing Drugs
Booth, L. A., Roberts, J. L., Cruickshanks, N. A., Grant, S., Poklepovic, A. S., & Dent, P. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0172 · Cited by 42
Bak, D., Kang, S. H., Choi, D. R., Gil, M. N., Yu, K. S., Jeong, J. H., Lee, N., LEE, J.-H., Jeong, Y., Kim, D. K., et al. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3196 · Cited by 41
Vlachostergios, P. J., Hatzidaki, E., Befani, C. D., Liakos, P., & Papandreou, C. N. (2013) · Investigational New Drugs · doi:10.1007/s10637-013-9968-1 · Cited by 39
Liu, B., Pang, B., Hou, X., Fan, H., Liang, N., Zheng, S., Feng, B., Liu, W., Guo, H., Xu, S., et al. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.02.028 · Cited by 39
Liao, C.-L., Chen, C., Chang, Y., Liu, G., Hung, H., Hsieh, T.-Y., & Lin, C. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf501234b · Cited by 38
Alterations in cellular metabolome after pharmacological inhibition of N otch in glioblastoma cells
Kahlert, U. D., Cheng, M., Koch, K., Marchionni, L., Fan, X., Raabe, E. H., Maciaczyk, J., Glunde, K., & Eberhart, C. G. (2015) · International Journal of Cancer · doi:10.1002/ijc.29873 · Cited by 37
How to train glioma cells to die: molecular challenges in cell death
Wojton, J., Meisen, W. H., & Kaur, B. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1980-1 · Cited by 36
XBP1 silencing decreases glioma cell viability and glycolysis possibly by inhibiting HK2 expression
Liu, Y., Hou, X., Liu, M., Yang, Z., Bi, Y., Zou, H., Wu, J., Che, H., Li, C., Wang, X., et al. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-2003-y · Cited by 36
ER stress in temozolomide-treated glioblastomas interferes with DNA repair and induces apoptosis
Weatherbee, J. L., Kraus, J., & Ross, A. H. (2016) · Oncotarget · doi:10.18632/oncotarget.9907 · Cited by 36
Targeting X box-binding protein-1 (XBP1) enhances sensitivity of glioma cells to oxidative stress
Liu, Y., Zhang, X., Liang, Y., Yu, H., Chen, X., Zheng, T., Zheng, B., Wang, L., Zhao, L., Shi, C., et al. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01155.x · Cited by 33
Targeting the Unfolded Protein Response in Glioblastoma Cells with the Fusion Protein EGF-SubA
Prabhu, A. H., Sarcar, B., Kahali, S., Shan, Y., & Chinnaiyan, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052265 · Cited by 33
The renewed battle against RAS-mutant cancers
Zhang, F., & Cheong, J. K. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2155-8 · Cited by 32
Microenvironment and autophagy cross-talk: Implications in cancer therapy
Gomes, L. R., Vessoni, A. T., & Menck, C. F. M. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.031 · Cited by 32
Liu, X., Sun, K., Wang, H., & Dai, Y. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.04.001 · Cited by 32
Bax Activation Blocks Self-Renewal and Induces Apoptosis of Human Glioblastoma Stem Cells
Daniele, S., Pietrobono, D., Costa, B., Giustiniano, M., Pietra, V. L., Giacomelli, C., Regina, G. L., Silvestri, R., Taliani, S., Trincavelli, M. L., et al. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00023 · Cited by 32
Dantas-Barbosa, C., Bergthold, G., Daudigeos‐Dubus, E., Blockus, H., Boylan, J. F., Ferreira, C., Puget, S., Abely, M., Vassal, G., Grill, J., et al. (2014) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000190 · Cited by 30
Soehngen, E., Schaefer, A., Koeritzer, J., Huelsmeyer, V., Zimmer, C., Ringel, F. A., Gempt, J., & Schlegel, J. (2013) · Brain Tumor Pathology · doi:10.1007/s10014-013-0170-0 · Cited by 30
MIAO, W., Liu, X., Wang, H., Fan, Y., Lian, S., Yang, X., Wang, X., GUO, G., LI, Q., & WANG, S. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3255 · Cited by 30
Jalota, A., Kumar, M., Das, B. C., Yadav, A. K., Chosdol, K., & Sinha, S. (2016) · Tumor Biology · doi:10.1007/s13277-016-5089-8 · Cited by 30
p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading
Guerra, E., Cimadamore, A., Simeone, P., Vacca, G., Lattanzio, R., Botti, G., Gatta, V., D’Aurora, M., Simionati, B., Piantelli, M., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2713-3 · Cited by 30
Zhu, Z., Du, S., Ding, F., Guo, S., Ying, G., & Zhao, Y. (2016) · Europe PMC (PubMed Central) · Cited by 29
BH3 Mimetics Reactivate Autophagic Cell Death in Anoxia-Resistant Malignant Glioma Cells
Hetschko, H., Voss, V., Senft, C., Seifert, V., Prehn, J. H. M., & Kögel, D. (2008) · Neoplasia · doi:10.1593/neo.07842 · Cited by 28
HMGA2 sustains self-renewal and invasiveness of glioma-initiating cells
Zhong, X., Liu, X., Li, Y., Cheng, M., Wang, W., Tian, K., Mu, L., Zeng, T., Liu, Y., Jiang, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9744 · Cited by 28
Han, T. J., Cho, B. J., Choi, E. J., Kim, D. H., Song, S. H., Paek, S. H., & Kim, I. A. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2231-9 · Cited by 28
GSK621 Targets Glioma Cells via Activating AMP-Activated Protein Kinase Signalings
Jiang, H., Liu, W. X., Zhan, S., Pan, Y., Bian, L., Sun, B., Sun, Q., & Pan, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161017 · Cited by 27
Recent Medical Management of Glioblastoma
Johnson, D. R., & Chang, S. M. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3146-6_3 · Cited by 26
Paul-Samojedny, M., Pudełko, A., Kowalczyk, M., Fila-Daniłow, A., Suchanek-Raif, R., Borkowska, P., & Kowalski, J. (2016) · BioDrugs · doi:10.1007/s40259-016-0160-y · Cited by 26
Gwak, H., Shingu, T., Chumbalkar, V. C., Hwang, Y., Dejournett, R. E., Latha, K., Koul, D., Yung, W. K. A., Powis, G., Farrell, N. P., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25394 · Cited by 25
CHEN, C.-M., Syu, J.-P., Way, T., Huang, L., Kuo, S., Lin, C., & Lin, C. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2332 · Cited by 24
Zhao, Y., Xiao, Z., Chen, W., Yang, J., Li, T., & FAN, B. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3664 · Cited by 23
Antiangiogenic Therapy for Glioblastoma: Complex Biology and Complicated Results
Gilbert, M. R. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.5364 · Cited by 22
Foster, K. A., Jane, E. P., Premkumar, D. R., et al. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1575-2 · Cited by 15
Martin, S., Lovat, P. E., & Redfern, C. P. F. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24996 · Cited by 9
Eat this, not that! How selective autophagy helps cancer cells survive
Mathew, R., & White, E. (2015) · Molecular & Cellular Oncology · doi:10.4161/23723556.2014.975638 · Cited by 8
Autophagic tumor stroma: A biofuel for cancer growth
Iozzo, R. V. (2011) · Cell Cycle · doi:10.4161/cc.10.19.17124 · Cited by 7
Cited by
Molecular mechanisms of cell death in neurological diseases
Moujalled, D., Strasser, A., & Liddell, J. R. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-021-00814-y · Cited by 749
Statins: a repurposed drug to fight cancer
Jiang, W., Hu, J.-W., He, X.-R., Jin, W.-L., & He, X.-Y. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02041-2 · Cited by 417
Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review
Singh, N., Miner, A., Hennis, L., & Mittal, S. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.79 · Cited by 398
Tomar, M. S., Kumar, A., Srivastava, C., & Shrivastava, A. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188616 · Cited by 325
Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
JIAPAER, S., FURUTA, T., TANAKA, S., KITABAYASHI, T., & NAKADA, M. (2018) · Neurologia medico-chirurgica · doi:10.2176/nmc.ra.2018-0141 · Cited by 324
Metadata
- Authors
- Hombach-Klonisch, S., Mehrpour, M., Shojaei, S., Harlos, C., Pitz, M., Hamai, A., Siemianowicz, K., Likus, W., Wiechec, E., Toyota, B. D., Hoshyar, R., Seyfoori, A., Sepehri, Z., Ande, S. R., Khadem, F., Akbari, M., Gorman, A. M., Samali, A., Klonisch, T., & Ghavami, S.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 184
- Pages
- 13-41
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2768032770
- Cited by
- 292
- References
- 377
- FWCI
- 14.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.